Skip to main content

Advertisement

Fig. 2 | BMC Cancer

Fig. 2

From: Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

Fig. 2

Overall survival (OS) and Recurrence-free survival (RFS) analyses of patients with ccRCC based on CCL17 expression. Kaplan-Meier analysis of OS in All Patients group (n = 286) (a); and in SSIGN low-risk group (n = 218) (b); in SSIGN mediate- and high-risk group (n = 68) (c); Kaplan-Meier analysis of RFS in All Patients group (n = 262) (d); in SSIGN low-risk group (n = 156) (e); in SSIGN mediate- and high-risk group (n = 106) (f). P value was calculated by log-rank test

Back to article page